• linkedin
  • Increase Font
  • Sharebar

    5-ARI may have adverse metabolic effects

    While the sexual side effects of finasteride (Proscar) and dutasteride (Avodart) are well known, a small but increasing body of research suggests that these agents potentially may have some metabolic effects in men who undergo long-term therapy.

    Most of this evidence to date comes from basic science investigations, but the most recently published report pointing in this direction is a retrospective analysis of patient registry data. Authors of the new study say that long-term dutasteride therapy was associated with increased glucose, increased glycated hemoglobin (HbA1c), and altered lipid profiles.

    Read: Side effects of modern PCa treatments compared

    “I think our study corroborates the clinical science, which is limited, but also the basic science, which is significant,” said first author Abdulmaged M. Traish, PhD, MBA, of Boston University School of Medicine, Boston.

    While further study is warranted before any firm clinical conclusions can be drawn, Dr. Traish said he hoped urologists, endocrinologists, and others would at least take time to read the medical literature on the potential association, and share that with patients.

    “Men with BPH may have to take these drugs for many years,” Dr. Traish said in an interview with Urology Times. “Clinicians should really discuss the potential benefit and potential risks with patients before starting therapy.”

    The retrospective study, published online in Hormone Molecular Biology and Clinical Investigation (June 21, 2017), included a cohort of 230 men treated with dutasteride for lower urinary tract symptoms secondary to BPH, and another cohort of 230 men treated with tamsulosin (Flomax). The men were followed for 36-42 months.

    Also see - Life vs. quality of life: A delicate balance

    For the group of men treated with dutasteride, investigators noted a progressive increase in fasting blood glucose levels from baseline (6.77+/–0.55 mg/dL; p<.0001) along with an increase in HbA1c (0.7+/–0.02%; p<.0001). By comparison, no such rises were seen in the cohort of men treated with tamsulosin.

    Dutasteride also appeared to be associated with increases in aspartate transaminase and aminotransferase activity, while tamsulosin was not. This suggests inhibition of 5-alpha-reductase may bring about biochemical changes in liver function that may represent alterations in liver metabolism or increased inflammation, Dr. Traish and colleagues wrote.

    Next: Cholesterol, sexual side effects examined

    Andrew Bowser
    Andrew Bowser is a medical writer based in Brooklyn, New York.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available